Microginin KR604
| Internal ID | 5fd29eb5-ae0c-461c-8106-0fe7075cdc19 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (2S)-1-[(2S)-2-[[(2R)-2-[[(2S,3S)-2-hydroxy-3-(methylamino)decanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]-methylamino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid |
| SMILES (Canonical) | CCCCCCCC(C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N(C)C(CC(C)C)C(=O)N2CCCC2C(=O)O)O)NC |
| SMILES (Isomeric) | CCCCCCC[C@@H]([C@@H](C(=O)N[C@H](CC1=CC=C(C=C1)O)C(=O)N(C)[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)O)O)NC |
| InChI | InChI=1S/C32H52N4O7/c1-6-7-8-9-10-12-24(33-4)28(38)29(39)34-25(20-22-14-16-23(37)17-15-22)30(40)35(5)27(19-21(2)3)31(41)36-18-11-13-26(36)32(42)43/h14-17,21,24-28,33,37-38H,6-13,18-20H2,1-5H3,(H,34,39)(H,42,43)/t24-,25+,26-,27-,28-/m0/s1 |
| InChI Key | GPDYVBKEQKRQEM-IXSXPGEMSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C32H52N4O7 |
| Molecular Weight | 604.80 g/mol |
| Exact Mass | 604.38360001 g/mol |
| Topological Polar Surface Area (TPSA) | 160.00 Ų |
| XlogP | 2.20 |
| Atomic LogP (AlogP) | 2.68 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 5 |
| Rotatable Bonds | 18 |
| (2S)-1-[(2S)-2-[[(2R)-2-[[(2S,3S)-2-hydroxy-3-(methylamino)decanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]-methylamino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-((2S)-2-(((2R)-2-(((2S,3S)-2-hydroxy-3-(methylamino)decanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)-methylamino)-4-methylpentanoyl)pyrrolidine-2-carboxylic acid |
| (2S)-1-((2S)-2-((2R)-2-(((2S,3S)-1,2-dihydroxy-3-(methylamino)decylidene)amino)-3-(4-hydroxyphenyl)-N-methylpropanamido)-4-methylpentanoyl)pyrrolidine-2-carboxylate |
| (2S)-1-[(2S)-2-[(2R)-2-{[(2S,3S)-1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-N-methylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylate |
| RefChem:158651 |
| CHEBI:213856 |
| DTXSID101334990 |
| N-[(2S,3S)-2-Hydroxy-3-(methylamino)decanoyl]-D-tyrosyl-N-methyl-L-leucyl-L-proline |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5224 | 52.24% |
| Caco-2 | - | 0.8335 | 83.35% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.7571 | 75.71% |
| Subcellular localzation | Mitochondria | 0.6564 | 65.64% |
| OATP2B1 inhibitior | - | 0.5703 | 57.03% |
| OATP1B1 inhibitior | + | 0.8663 | 86.63% |
| OATP1B3 inhibitior | + | 0.9069 | 90.69% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.8222 | 82.22% |
| P-glycoprotein inhibitior | + | 0.7179 | 71.79% |
| P-glycoprotein substrate | + | 0.8594 | 85.94% |
| CYP3A4 substrate | + | 0.7127 | 71.27% |
| CYP2C9 substrate | - | 0.6006 | 60.06% |
| CYP2D6 substrate | - | 0.7435 | 74.35% |
| CYP3A4 inhibition | - | 0.7010 | 70.10% |
| CYP2C9 inhibition | - | 0.8346 | 83.46% |
| CYP2C19 inhibition | - | 0.8577 | 85.77% |
| CYP2D6 inhibition | - | 0.8883 | 88.83% |
| CYP1A2 inhibition | - | 0.9106 | 91.06% |
| CYP2C8 inhibition | + | 0.5158 | 51.58% |
| CYP inhibitory promiscuity | - | 0.9074 | 90.74% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.9100 | 91.00% |
| Carcinogenicity (trinary) | Non-required | 0.6981 | 69.81% |
| Eye corrosion | - | 0.9904 | 99.04% |
| Eye irritation | - | 0.9393 | 93.93% |
| Skin irritation | - | 0.7828 | 78.28% |
| Skin corrosion | - | 0.9263 | 92.63% |
| Ames mutagenesis | - | 0.8637 | 86.37% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.5476 | 54.76% |
| Micronuclear | + | 0.7500 | 75.00% |
| Hepatotoxicity | + | 0.6159 | 61.59% |
| skin sensitisation | - | 0.8783 | 87.83% |
| Respiratory toxicity | + | 0.7333 | 73.33% |
| Reproductive toxicity | + | 0.9111 | 91.11% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.7404 | 74.04% |
| Acute Oral Toxicity (c) | III | 0.6533 | 65.33% |
| Estrogen receptor binding | + | 0.7305 | 73.05% |
| Androgen receptor binding | + | 0.6851 | 68.51% |
| Thyroid receptor binding | - | 0.5106 | 51.06% |
| Glucocorticoid receptor binding | + | 0.6308 | 63.08% |
| Aromatase binding | + | 0.5632 | 56.32% |
| PPAR gamma | + | 0.5991 | 59.91% |
| Honey bee toxicity | - | 0.8573 | 85.73% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | + | 0.5699 | 56.99% |
| Fish aquatic toxicity | + | 0.9591 | 95.91% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.97% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.53% | 96.61% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 98.59% | 89.63% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.60% | 96.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.49% | 93.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.17% | 100.00% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 96.97% | 91.81% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 95.99% | 98.33% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.98% | 99.17% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 95.57% | 100.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 95.46% | 90.17% |
| CHEMBL268 | P43235 | Cathepsin K | 95.31% | 96.85% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.08% | 98.10% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.98% | 90.71% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 94.45% | 92.86% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.58% | 97.64% |
| CHEMBL1907599 | P05556 | Integrin alpha-4/beta-1 | 93.31% | 92.86% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 92.92% | 95.89% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.91% | 100.00% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 91.72% | 92.12% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 91.22% | 98.24% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 91.15% | 91.19% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.01% | 95.89% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.50% | 90.08% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 89.69% | 97.14% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 89.16% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 89.00% | 95.56% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.62% | 93.00% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 87.66% | 97.25% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 86.89% | 97.29% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 86.48% | 94.66% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 85.29% | 90.20% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 85.19% | 96.37% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 84.65% | 95.17% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 83.79% | 96.38% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 83.51% | 97.50% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 83.23% | 93.10% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.75% | 100.00% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 82.54% | 95.52% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 82.49% | 94.50% |
| CHEMBL1978 | P11511 | Cytochrome P450 19A1 | 82.40% | 91.76% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 82.23% | 94.45% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 82.17% | 96.90% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 82.10% | 97.09% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.98% | 94.33% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 81.92% | 92.08% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 80.88% | 97.50% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 80.65% | 95.34% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 80.57% | 96.67% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683792 |
| LOTUS | LTS0243805 |
| wikiData | Q105014787 |